SCHEMBL6794551

SCHEMBL6794551

NCCCC[C@@H](C(=O)O)N1C(=O)CCCCCCCC1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
PKM P14618 1/20 0.42
GSR P00390 1/20 0.41
RNPEP Q9H4A4 1/20 0.40
CPB2 Q96IY4 6/20 0.37
LMNA P02545 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA3 P07451 1/20 0.33
CA4 P22748 1/20 0.33
CA6 P23280 1/20 0.33
CA5A P35218 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
CA13 Q8N1Q1 1/20 0.33
CA14 Q9ULX7 1/20 0.33
CA5B Q9Y2D0 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL195776 0.98 ALDH1A1 (0.43) ALDH1A1PKMGSRRNPEPCPB2
SCHEMBL1696964 0.95 ALDH1A1 (0.46) ALDH1A1PKMGSRRNPEPCPB2
SCHEMBL1696971 0.92 ALDH1A1 (0.49) ALDH1A1PKMGSRRNPEPCPB2
SCHEMBL28490356 0.92 ALDH1A1 (0.49) ALDH1A1PKMGSRRNPEPCPB2
SCHEMBL1437767 0.87 ALDH1A1 (0.50) ALDH1A1PKMGSRRNPEPCPB2
SCHEMBL1696968 0.85 GSR (0.44) ALDH1A1PKMGSRRNPEPCPB2
SCHEMBL1696991 0.82 ALDH1A1 (0.41) ALDH1A1PKMGSRRNPEPCPB2
SCHEMBL1696978 0.82 ALDH1A1 (0.40) ALDH1A1PKMGSRRNPEPCPB2
Lysine SCHEMBL5606291 0.82 GSR (0.48) ALDH1A1PKMGSRCYP1A2CYP2C19
SCHEMBL12478991 0.76 ALDH1A1 (0.43) ALDH1A1PKMLMNACA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6730686-B1 INCLUDING LOW DENSITY LIPOPROTEINS, TO TREAT OR PREVENT LIPID PEROXIDATION, AND TO TREAT OR PREVENT ATHEROSCLEROSIS KANSAS UNIVERSITY MEDICAL CENTER 2004-05-04 US disclosed
WO-2000022094-A2 METHODS FOR INHIBITING OXIDATIVE MODIFICATION OF PROTEINS KANSAS UNIVERSITY MEDICAL CENTER (US) 2000-04-20 WO disclosed